Neoadjuvant Treatment of Mismatch Repair-Deficient Colon Cancer - Clinically Meaningful?

N Engl J Med. 2024 Jun 6;390(21):2024-2025. doi: 10.1056/NEJMe2404601.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Colonic Neoplasms* / drug therapy
  • Colonic Neoplasms* / pathology
  • Colonic Neoplasms* / surgery
  • DNA Mismatch Repair*
  • Humans
  • Immune Checkpoint Inhibitors* / therapeutic use
  • Neoadjuvant Therapy*
  • Randomized Controlled Trials as Topic

Substances

  • Immune Checkpoint Inhibitors